Scientists reprogram brain cells to remove Alzheimer’s plaques with a single injection, showing a new approach to long-term ...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today highlighted data presented at the American Association ...

A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...

A new study by researchers at Fox Chase Cancer Center focusing on pancreatic cancer has shown that a new scoring system can ...

The stiffness of tumour tissue plays a role in how cancer spreads. Furthermore, stiff tumour tissue leaves traces in the ...

Researchers at Hannover Medical School (MHH) have developed a method for the efficient production of human immune cells, such ...

Worth up to $7 billion, Lilly’s second recent acquisition of a company in the space is centered around a cell therapy that’s ...

A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically ...

Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in ...

A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...

CAR-T cell therapy has transformed treatment for certain cancers by engineering a patient’s immune cells to identify and ...

Roswell Park Comprehensive Cancer Center has opened a clinical trial to test whether CAR T-cell therapy—successful in some blood cancers—can treat autoimmune diseases like systemic sclerosis, with ...